601![Phase 1 Clinical Trial Of The Candidate Anti-Sickling Agent Aes-103 In Adults With Sickle Cell Anemia Gregory J. Kato, MD, Marlene Peters Lawrence, RN, Laurel G. Mendelsohn, BS, Rehan Saiyed, BS, Xunde Wang, PhD, Anna K. Phase 1 Clinical Trial Of The Candidate Anti-Sickling Agent Aes-103 In Adults With Sickle Cell Anemia Gregory J. Kato, MD, Marlene Peters Lawrence, RN, Laurel G. Mendelsohn, BS, Rehan Saiyed, BS, Xunde Wang, PhD, Anna K.](https://www.pdfsearch.io/img/add90c43e5d6f5f57fd07b68daa2bdb0.jpg) | Add to Reading ListSource URL: aesrx.comLanguage: English - Date: 2013-12-19 11:36:38
|
---|
602![Preparticipation Physical Evaluation HISTORY Name__________________________________Sex______Age______Date of Birth__________________ Address________________________________________________________________________________ Preparticipation Physical Evaluation HISTORY Name__________________________________Sex______Age______Date of Birth__________________ Address________________________________________________________________________________](https://www.pdfsearch.io/img/2be98ab4335ce0ca5053550508d0bfdf.jpg) | Add to Reading ListSource URL: www.dakotacollege.eduLanguage: English - Date: 2014-04-14 13:25:49
|
---|
603![Anti-sickling Agent Aes-103 Protects Red Blood Cells From Hemolysis by Mechanical Agitation Kevin Y. Wang, Leah Pedoeim, Laurel Mendelsohn, Jim Nichols, Xunde Wang, and Gregory J. Kato Hematology Branch, National Heart L Anti-sickling Agent Aes-103 Protects Red Blood Cells From Hemolysis by Mechanical Agitation Kevin Y. Wang, Leah Pedoeim, Laurel Mendelsohn, Jim Nichols, Xunde Wang, and Gregory J. Kato Hematology Branch, National Heart L](https://www.pdfsearch.io/img/cc62c28b9243aec798472b35b1f28f9d.jpg) | Add to Reading ListSource URL: aesrx.comLanguage: English - Date: 2013-12-19 11:36:31
|
---|
604![research paper 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells, Osheiza Abdulmalik1,* Martin K. Safo2,* research paper 5-hydroxymethyl-2-furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells, Osheiza Abdulmalik1,* Martin K. Safo2,*](https://www.pdfsearch.io/img/a5c51568e58a6e4be251ad53f3829079.jpg) | Add to Reading ListSource URL: aesrx.comLanguage: English - Date: 2013-09-10 12:18:02
|
---|
605![](https://www.pdfsearch.io/img/bbd73a69c01136b1c1707dd84f78b198.jpg) | Add to Reading ListSource URL: alabamaadministrativecode.state.al.usLanguage: English - Date: 2012-12-24 13:06:47
|
---|
606![Request for Applications[removed]: New York State Sickle Cell Services Program - Transition Program for Young Adults to Adult Medical Care Request for Applications[removed]: New York State Sickle Cell Services Program - Transition Program for Young Adults to Adult Medical Care](https://www.pdfsearch.io/img/a1de73e07e75e58932673f77c69ee9a2.jpg) | Add to Reading ListSource URL: www.health.ny.govLanguage: English - Date: 2012-09-26 16:37:15
|
---|
607![](https://www.pdfsearch.io/img/7319db85ccf24622f1dc8064852294b4.jpg) | Add to Reading ListSource URL: alabamaadministrativecode.state.al.usLanguage: English - Date: 2012-12-24 13:06:47
|
---|
608![* A splenia or splenic dysfunction (splenectomy, sickle cell disease, coeliac syndrome); chronic renal, heart, lung, liver disease, diabetes mellitus, complement deficiency, immunosuppressive conditions; CSF leak, coc * A splenia or splenic dysfunction (splenectomy, sickle cell disease, coeliac syndrome); chronic renal, heart, lung, liver disease, diabetes mellitus, complement deficiency, immunosuppressive conditions; CSF leak, coc](https://www.pdfsearch.io/img/fff914de2a436a2e94fa93e7ed13de57.jpg) | Add to Reading ListSource URL: hse.ie |
---|
609![](https://www.pdfsearch.io/img/a5ee5fcd647f3380532e06ef0ba401ad.jpg) | Add to Reading ListSource URL: www.bcshguidelines.comLanguage: English - Date: 2012-07-23 10:22:06
|
---|
610![Adult Pneumococcal Vaccination Guide for Health Care Professionals Two pneumococcal vaccines are approved by NACI for use in adults (19 years and older): a 23valent pneumococcal polysaccharide vaccine (PPSV23) and a 13-v Adult Pneumococcal Vaccination Guide for Health Care Professionals Two pneumococcal vaccines are approved by NACI for use in adults (19 years and older): a 23valent pneumococcal polysaccharide vaccine (PPSV23) and a 13-v](https://www.pdfsearch.io/img/1f0cfd830a1dbac492439859dd89859d.jpg) | Add to Reading ListSource URL: novascotia.caLanguage: English - Date: 2014-04-01 09:02:45
|
---|